Ignite Creation Date:
2024-05-06 @ 3:15 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04567732
Status:
RECRUITING
Last Update Posted:
2023-07-19
First Post:
2020-09-23
Brief Title:
Bilateral Knee Osteoarthritis Intra-articular Injection of Filtered Autologous Adipose Tissue Versus Placebo
Sponsor:
Istituto Ortopedico Rizzoli
Organization:
Istituto Ortopedico Rizzoli
Study Overview
Official Title:
Randomized Double Blind Clinical Study on the Treatment of Bilateral Knee Arthrosis Intra-articular Injection of Filtered Autologous Adipose Tissue Versus Placebo
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to assess the radiological and clinical outcomes comparing two different treatments Filtered Autologous Adipose Tissue versus Placebo in patients affecting bilateral knee osteoarthritis
After be randomized every patient will be treated in both legs one leg with Adipose Tissue and the other one with Placebo
After be randomized every patient will be treated in both legs one leg with Adipose Tissue and the other one with Placebo
Detailed Description:
All patients who meet the inclusion criteria and giving written informed consent will be randomized
Every patient will be treated with a single injection of Filtered Autologous Adipose Tissue in one knee and single injection of Placebo in the other based on the randomization
After the treatment patients will be followed up to 24 months
Every patient will be treated with a single injection of Filtered Autologous Adipose Tissue in one knee and single injection of Placebo in the other based on the randomization
After the treatment patients will be followed up to 24 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None